Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A patent application filed by Google indicates that the company is looking to develop an electronic health records (EHR) system that uses AI to predict a patient’s future medical events.
Researchers with MIT’s Computer Science and Artificial Intelligence Lab are working to develop an algorithm that can automatically “debias” data for AI models—an issue that has plagued the technology amid its growing prevalence in the medical field.
Telemedicine rates rose when temperatures plummeted during the polar vortex in late January, according to a report by WOOD-TV, local NBC affiliate in Grand Rapids, Michigan.
The nation’s third-largest nonprofit health system, Providence St. Joseph Health, has created a for-profit population health management company called Ayin Health Solutions.
An AI-based platform that prepares patients for total joint replacement surgery was associated with shorter hospital stays, according to a study published in the Annals of Translational Medicine.
Some obesity-related cancers—including colorectal, gallbladder, kidney and pancreatic cancer—are on the rise among adults aged 25 to 49, compared to older generations, according to new research published inThe Lancet: Public Healthon World Cancer Day.
Russian researchers and radiologists have developed AI software that can distinguish and subsequently mark lung cancers on a CT scan within 20 seconds.
Treatment at minority-serving hospitals (MSHs) is associated with significantly lower odds of receiving palliative care, compared with treatment at a non-minority-serving hospital, according to new research published inJAMA Network Open.
